United Therapeutics | UTHR - Creditori Commerciali

Prezzo Delle Azioni
567.16
Cambio Giornaliero
-5.69 -0.99%
Mensile
4.72%
Annuale
94.65%
Q2 Previsione
555.02




Creditori Commerciali Cambiamento Data
Amarin USD 45.36M 8.64M 2025-12
Ardelyx USD 19.24M 845K 2025-12
Baxter International USD 999M 46M 2025-12
Bayer EUR 7.08B 700M 2025-12
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Emergent BioSolutions USD 112.2M 500K 2023-12
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Gilead Sciences USD 715M 93M 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Insmed USD 79.91M 316K 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
J&J USD 10.46B 1.53B 2026-03
Lexicon Pharmaceuticals USD 3.08M 714K 2025-12
Moderna USD 317M 50M 2025-12
Omeros USD 8.84M 4.42M 2025-06
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 45.49M 8.87M 2025-12
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12
United Therapeutics USD 7.1M 460.9M 2025-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12